RAP 0.00% 20.5¢ raptor resources limited

Many microcaps that are having their clinical resultsanalysed by...

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,251 Posts.
    lightbulb Created with Sketch. 713

    Many microcaps that are having their clinical resultsanalysed by a third party will go into a trading halt between data lock and unblinding.I think the headset is better to be safe than sorry.  So the explanation for the delay proposedhere makes perfect to me.


    Reading the numerous posts here the main difference ofopinion I would have with them is peoples confidence in the reproducibility ofresults arising from “studies” as opposed to clinical trials.There is actually a world of difference between a study andtrial.  


    But on good results everyone can go about their daily livesand never give this another thought. On negative results there will be the question “why” – theanswer to which will nearly certainly involve getting your head around complicatedtrial methodology mumbo-jumbo which won’t make anyone one iota happier.So the first option is definitely the best one.

    Last edited by Southoz: 25/10/18
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.